Asker Healthcare Group revenue and financials

ASKER · Nasdaq Stockholm · SEK

kr 66.30−0.60%−kr 0.40

Close · October 7, 2026

In the fiscal year ended December 2025, Asker Healthcare Group reported revenue of kr 16.79B (+11.73% year over year). Net income was kr 492M, a net margin of 2.9%.

Annual revenue · 2025: kr 16.79B
  1. kr 11.72B2022
  2. kr 13.45B2023
  3. kr 15.03B2024
  4. kr 16.79B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+11.73%
2025 vs 2024
Net income growth
+36.67%
2025 vs 2024
Net margin
2.9%
2024: 2.4%

Financial data

Amounts in millions of SEK; per-share values in SEK; shares in millions.

ItemQ2 2026Q1 2026Q4 2025Q2 2025Q1 2025
Total revenue4,6864,5214,6763,9873,995
Cost of revenue2,7212,6572,7472,3572,367
Gross profit1,9661,8641,9291,6301,629
Selling, general and administrative1,6481,5661,6361,3531,378
Operating income349310281249238
EBIT408405290249405
EBITDA408405290249405
Interest expense12414811877.0271
Pre-tax income284257172172134
Income tax59.060.036.039.039.0
Net income21919313012991.0
Net income to common shareholders21919313012960.0
Basic EPS0.570.500.340.340.19
Diluted EPS0.570.500.340.340.19
Average shares (basic)383383383383324
Average shares (diluted)383383383383324